Identification of the biosynthetic gene cluster for the pacidamycin group of peptidyl nucleoside antibiotics
- 8 September 2010
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (39) , 16828-16833
Abstract
Pacidamycins are a family of uridyl tetra/pentapeptide antibiotics that act on the translocase MraY to block bacterial cell wall assembly. To elucidate the biosynthetic logic of pacidamcyins, a putative gene cluster was identified by 454 shotgun genome sequencing of the producer Streptomyces coeruleorubidus NRRL 18370. The 31-kb gene cluster encodes 22 proteins (PacA-V), including highly dissociated nonribosomal peptide synthetase (NRPS) modules and a variety of tailoring enzymes. Gene deletions confirmed that two NRPSs, PacP and PacO, are required for the biosynthesis of pacidamycins. Heterologous expression and in vitro assays of PacL, PacO, and PacP established reversible formation of m -Tyr-AMP, l -Ala-AMP, and diaminopropionyl-AMP, respectively, consistent with the amino acids found in pacidamycin scaffolds. The unusual Ala 4 -Phe 5 dipeptidyl ureido linkage was formed during in vitro assays containing purified PacL, PacJ, PacN, and PacO. Both the genetic and enzymatic studies validate identification of the biosynthetic genes for this subclass of uridyl peptide antibiotics and provide the basis for future mechanistic study of their biosynthesis.Keywords
This publication has 28 references indexed in Scilit:
- Antimicrobial nucleoside antibiotics targeting cell wall assembly: Recent advances in structure–function studies and nucleoside biosynthesisNatural Product Reports, 2009
- SylC Catalyzes Ureido-Bond Formation During Biosynthesis of the Proteasome Inhibitor Syringolin AJournal of the American Chemical Society, 2009
- Characterization of the Polyoxin Biosynthetic Gene Cluster from Streptomyces cacaoi and Engineered Production of Polyoxin HJournal of Biological Chemistry, 2009
- Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycinBioorganic & Medicinal Chemistry Letters, 2003
- Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compoundsBioorganic & Medicinal Chemistry Letters, 2003
- Liposidomycin B inhibits In Vitro Formation of Polyprenyl (pyro)phosphate N-Acetylglucosamine, an Intermediate in Glycoconjugate BiosynthesisThe Journal of Antibiotics, 1997
- Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82, 11372.The Journal of Antibiotics, 1994
- Mureidomycin A, a new inhibitor of bacterial peptidoglycan synthesisAntimicrobial Agents and Chemotherapy, 1991
- Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. II. Isolation and structural elucidation.The Journal of Antibiotics, 1989
- Tunicamycin inhibits the formation of lipid intermediate in cell-free peptidoglycan synthesis of bacteria.Agricultural and Biological Chemistry, 1976